BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38783480)

  • 21. Substrate-dependent competency of the catalytic triad of prolyl oligopeptidase.
    Szeltner Z; Rea D; Juhász T; Renner V; Mucsi Z; Orosz G; Fülöp V; Polgár L
    J Biol Chem; 2002 Nov; 277(47):44597-605. PubMed ID: 12228249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity-based probes for monitoring postproline protease activity.
    Sabidó E; Tarragó T; Niessen S; Cravatt BF; Giralt E
    Chembiochem; 2009 Sep; 10(14):2361-6. PubMed ID: 19688784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 15N relaxation NMR studies of prolyl oligopeptidase, an 80 kDa enzyme, reveal a pre-existing equilibrium between different conformational states.
    Kichik N; Tarragó T; Claasen B; Gairí M; Millet O; Giralt E
    Chembiochem; 2011 Dec; 12(18):2737-9. PubMed ID: 22069228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel benzimidazole derivatives as effective inhibitors of prolyl oligopeptidase: synthesis,
    Shakoor A; Alam A; Jan F; Khan M; Ali M; Ullah S; Khan A; AlAsmari AF; Alasmari F; Al-Ghafri A; Al-Harrasi A
    Future Med Chem; 2024 Jan; 16(1):43-58. PubMed ID: 38054466
    [No Abstract]   [Full Text] [Related]  

  • 25. THE IMS PARADOX: A PERSPECTIVE ON STRUCTURAL ION MOBILITY-MASS SPECTROMETRY.
    McCabe JW; Hebert MJ; Shirzadeh M; Mallis CS; Denton JK; Walker TE; Russell DH
    Mass Spectrom Rev; 2021 May; 40(3):280-305. PubMed ID: 32608033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of Trypanosoma brucei oligopeptidase B broaden the paradigm of catalytic regulation in prolyl oligopeptidase family enzymes.
    Canning P; Rea D; Morty RE; Fülöp V
    PLoS One; 2013; 8(11):e79349. PubMed ID: 24265767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding protein-drug interactions using ion mobility-mass spectrometry.
    Eyers CE; Vonderach M; Ferries S; Jeacock K; Eyers PA
    Curr Opin Chem Biol; 2018 Feb; 42():167-176. PubMed ID: 29331721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structure and molecular dynamics of prolyl oligopeptidase from Microbulbifer arenaceous provide insights into catalytic and regulatory mechanisms.
    Huang P; Lv A; Yan Q; Jiang Z; Yang S
    Acta Crystallogr D Struct Biol; 2022 Jun; 78(Pt 6):735-751. PubMed ID: 35647921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms.
    Yadav P; Goyal VD; Gaur NK; Kumar A; Gokhale SM; Jamdar SN; Makde RD
    J Biol Chem; 2019 Jan; 294(1):89-100. PubMed ID: 30409909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrostatic environment at the active site of prolyl oligopeptidase is highly influential during substrate binding.
    Szeltner Z; Rea D; Renner V; Juliano L; Fülop V; Polgár L
    J Biol Chem; 2003 Dec; 278(49):48786-93. PubMed ID: 14514675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolyl oligopeptidase structure and dynamics.
    Rea D; Fülöp V
    CNS Neurol Disord Drug Targets; 2011 May; 10(3):306-10. PubMed ID: 21222626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliable Tracking In-Solution Protein Unfolding via Ultrafast Thermal Unfolding/Ion Mobility-Mass Spectrometry.
    Li G; Zheng S; Chen Y; Hou Z; Huang G
    Anal Chem; 2018 Jul; 90(13):7997-8001. PubMed ID: 29894165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of caffeoyl and cinnamoyl derivatives as potential prolyl oligopeptidase inhibitors.
    Adolpho LO; Marin D; Puigpinos A; Mendieta L; Tarragó T; Morel AF; Giralt E; Dalcol II
    Planta Med; 2013 Nov; 79(16):1531-5. PubMed ID: 24085498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrostatic effects and binding determinants in the catalysis of prolyl oligopeptidase. Site specific mutagenesis at the oxyanion binding site.
    Szeltner Z; Rea D; Renner V; Fulop V; Polgar L
    J Biol Chem; 2002 Nov; 277(45):42613-22. PubMed ID: 12202494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and localization of the mouse prolyl oligopeptidase gene.
    Kimura A; Yoshida I; Takagi N; Takahashi T
    J Biol Chem; 1999 Aug; 274(34):24047-53. PubMed ID: 10446174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligopeptidases, and the emergence of the prolyl oligopeptidase family.
    Barrett AJ; Rawlings ND
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):353-60. PubMed ID: 1515061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concerted structural changes in the peptidase and the propeller domains of prolyl oligopeptidase are required for substrate binding.
    Szeltner Z; Rea D; Juhász T; Renner V; Fülöp V; Polgár L
    J Mol Biol; 2004 Jul; 340(3):627-37. PubMed ID: 15210359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biological role of prolyl oligopeptidase and the procognitive potential of its peptidic inhibitors from food proteins.
    Taraszkiewicz A; Sinkiewicz I; Sommer A; Staroszczyk H
    Crit Rev Food Sci Nutr; 2024; 64(19):6567-6580. PubMed ID: 36798052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distance geometry protocol to generate conformations of natural products to structurally interpret ion mobility-mass spectrometry collision cross sections.
    Stow SM; Goodwin CR; Kliman M; Bachmann BO; McLean JA; Lybrand TP
    J Phys Chem B; 2014 Dec; 118(48):13812-20. PubMed ID: 25360896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced-fit mechanism for prolyl endopeptidase.
    Li M; Chen C; Davies DR; Chiu TK
    J Biol Chem; 2010 Jul; 285(28):21487-95. PubMed ID: 20444688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.